0.1014

2.73% 0.0026

Aspire Biopharma Holdings Inc (ASBP)

Overview News Price History Discussions Forecast

Aspire Biopharma Holdings Inc stock is traded at $0.1014, with a volume of 25.65M. It is up +2.73% in the last 24 hours and down -73.46% over the past month. Aspire Biopharma Holdings Inc developing next-generation absorption of medicine that will have an impact on the opioid crisis. The group engaged in the business of developing and marketing disruptive technology for novel delivery mechanisms for do-no-harm drugs. Its nanotechnology drug formulation directly targets pain and inflammation bypassing the gastrointestinal tracts.

Previous Close:

$0.0988

Open:

$0.109

24h Volume:

25.65M

Relative Volume:

0.78

Market Cap:

$10.90M

Revenue:

Net Income/Loss:

$-27.39M

P/E Ratio:

-0.0603

EPS:

-1.6803

Net Cash Flow:

$-2.09M

1W Performance:

+0.30%

1M Performance:

-73.46%

6M Performance:

-73.64%

1Y Performance:

+0.00%

1-Day Range:

$0.101

$0.109

1-Week Range:

$0.0965

$0.112

52-Week Range:

$0.088

$2.10

Aspire Biopharma Holdings Inc Stock (ASBP) Company Profile

Name

Aspire Biopharma Holdings Inc

Sector

Healthcare (1137)

Industry

Biotechnology (627)

Phone

561-704-8527

Address

23150 FASHION DRIVE, SUITE 232, ESTERO

Employee

Twitter

Next Earnings Date

Latest SEC Filings

ASBP's Discussions on Twitter

Compare ASBP with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
ASBP Aspire Biopharma Holdings Inc	0.1014	10.62M	0	-27.39M	-2.09M	-1.6803
VRTX Vertex Pharmaceuticals Inc	433.80	107.98B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	741.75	78.84B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	466.63	60.05B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	917.64	55.10B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	206.70	45.09B	447.02M	-1.18B	-906.14M	-6.1812

Aspire Biopharma Holdings Inc Stock (ASBP) Latest News

09:07 AM

Aspire Biopharma Submits Pre-IND Meeting Request and Briefing Package to U.S. FDA for Sublingual Aspirin Product for Treatment of Suspected Acute Myocardial Infarction (Heart Attack) - itemonline.com

09:07 AM

09:00 AM

Aspire Biopharma (NASDAQ: ASBP) Requests FDA Pre-IND Meeting on Sublingual AMI Aspirin - Stock Titan

09:00 AM

Nov 28, 2025

ASBPWAspire Biopharma Holdings Inc Latest Stock News & Market Updates - Stock Titan

Nov 28, 2025

Nov 27, 2025

Aspire BioPharma Welcomes Dr. Mark J. Jaroszeski as New Scientific Team Member - Morris County NJ News | Daily Record

Nov 27, 2025

Nov 26, 2025

ASBPAspire Biopharma Holdings Inc Latest Stock News & Market Updates - Stock Titan

Nov 26, 2025

Aspire Biopharma adds pioneering drug delivery expert to scientific team By Investing.com - Investing.com Nigeria

Nov 26, 2025

Aspire Biopharma adds pioneering drug delivery expert to scientific team - Investing.com

Nov 26, 2025

Nov 24, 2025

The time has not yet come to remove your chips from the table: Aspire Biopharma Holdings Inc (ASBP) - Setenews

Nov 24, 2025

Nov 22, 2025

What analysts say about Aspire Biopharma Holdings Inc stockFibonacci Retracement Levels & Small Budget Capital Growth - earlytimes.in

Nov 22, 2025

Nov 19, 2025

ASBPW Stock Institutional Owners - Quiver Quantitative

Nov 19, 2025

Nov 18, 2025

Nasdaq Stock Volume & Price Moves: Aspire Biopharma, NVIDIA, TeslaNews and Statistics - IndexBox

Nov 18, 2025

Why Gorilla Technology Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket - Benzinga

Nov 18, 2025

Nov 17, 2025

Aspire Biopharma Engages with Global Pharmaceutical Leaders at CPHI Frankfurt to Advance Partnership Discussions for its Sublingual High-Dose Aspirin - Pensacola News Journal

Nov 17, 2025

12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga

Nov 17, 2025

3 Penny Stocks to Watch Now, 11/17/25 - TipRanks

Nov 17, 2025